This past February, the exclusive, complimentary FDA Strategy Event by NAMSA took place. Together with Virtonomy GmbH, PAconsult GmbH, and Kalms Consulting GmbH, we were delighted to welcome numerous industry peers.
The three-hour sessions provided participants with valuable, practical insights into U.S. regulatory requirements. A particular highlight was the exchange with Dr. Adam Saltman (NAMSA), who shared exclusive insider tips drawing from his 12 years of experience as a Medical Officer at the U.S. FDA. In addition to intensive technical discussions and an interactive Q&A session, attendees made great use of the sponsored networking lunch to connect personally.
We would like to express our sincere thanks to all guests, our co-organizers, and the speaker for a thoroughly successful event series!
Event Details & Retrospective (For Information):
- Munich (February 24): Hosted by Virtonomy GmbH
- Ochsenhausen (February 25): Hosted by PAconsult GmbH
- Berlin (February 26): Hosted by Kalms Consulting GmbH
Key topics covered during the sessions:
- Strategies for handling increasing FDA requirements with limited resources
- Practical Do's and Don'ts for direct cooperation with the FDA
- Future outlook on the FDA's strategic direction
- Interactive Q&A session and real-world case studies
